Skip to main content

Functional Neurological Disorder and Dissociative Disorders in Women

  • Chapter
  • First Online:
Neurology and Psychiatry of Women

Abstract

This chapter provides a review of the epidemiology, phenomenology, pathophysiology, clinical evaluation, and treatment of functional neurological disorders (FND) and dissociative disorders, highlighting aspects that are specifically pertinent to women. There is also discussion about their overlap. Women outnumber men in FND, though evidence of sex-based prevalence differences in dissociative disorders is mixed. Both disorders share a lack of integration of specific neurological functions, often in the setting of a trauma history. Evidence-based treatment for both disorders is emerging, with no clear indication at this point that intervention effectiveness differs based on sex.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 79.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.

    Google Scholar 

  2. Trimble M, Reynolds EH. A brief history of hysteria: from the ancient to the modern. Hand Clin Neurol. 2016;139(Functional Neurological Disorders):3–10.

    CAS  Google Scholar 

  3. Stone J, Sharpe M, Rothwell PM, Warlow CP. The12-year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry. 2003;74(5):591–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Duncan R, Graham CD, Oto M. Outcome at 5-10 years in psychogenic nonepileptic seizures: what patients report vs. what family doctors report. Epilepsy Behav. 2014;37:71–4.

    PubMed  Google Scholar 

  5. Carson A, Lehn A. Epidemiology. Hand Clin Neurol. 2016;139(Functional Neurological Disorders):47–60.

    CAS  Google Scholar 

  6. Stone J, Carson A, Duncan R, Roberts R, Warlow C, Coleman R, et al. Who is referred to neurology clinics? – the diagnoses made in 3781 new patients. Clin Neurol Neurosurg. 2010;112(9):747–51.

    CAS  PubMed  Google Scholar 

  7. Stone J, Carson A. An integrated approach to other functional neurological symptoms and related disorders. In: Dworetzky B, Baslet G, editors. Psychogenic nonepileptic seizures: towards the integration of care. New York: Oxford; 2017. p. 290–307.

    Google Scholar 

  8. Ladwig KH, Marten-Mittag B, Formanek B, Dammann G. Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol. 2000;16(6):511–8.

    CAS  PubMed  Google Scholar 

  9. Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry. 2005;62(8):903–10.

    PubMed  Google Scholar 

  10. Stone J, Smyth R, Carson A, Lewis S, Prescott R, Warlow C, et al. Systematic review of misdiagnosis of conversion symptoms and “hysteria”. BMJ. 2005;331(7523):989.

    PubMed  PubMed Central  Google Scholar 

  11. Kotagal P, Costa M, Wyllie E, Wolgamuth B. Paroxysmal nonepileptic events in children and adolescents. Pediatrics. 2002;110(4):e46.

    PubMed  Google Scholar 

  12. Duncan R, Oto M, Martin E, Pelosi A. Late onset psychogenic nonepileptic attacks. Neurology. 2006;66(11):1644–7.

    PubMed  Google Scholar 

  13. Stone J. Functional neurological disorders: the neurological assessment as treatment. Neurophysiol Clin. 2014;44(4):363–73.

    CAS  PubMed  Google Scholar 

  14. Morgante F, Edwards MJ, Espay AJ. Psychogenic movement disorders. Continuum (Minneap Minn). 2013;19(5 Movement Disorders):1383–96.

    Google Scholar 

  15. LaFrance WC, Baker GA, Duncan R, Goldstein LH, Reuber M. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach, a report from the international league against epilepsy nonepileptic seizures task force. Epilepsia. 2013;54(11):2005–18.

    PubMed  Google Scholar 

  16. Alving J. Serum prolactin levels are elevated also after pseudo-epileptic seizures. Seizure. 1998;7(2):85–9.

    CAS  PubMed  Google Scholar 

  17. Chen DK, So YT, Fisher RS. Therapeutics and technology assessment subcommittee of the American Academy of Neurology. Use of serum prolactin in diagnosing epileptic seizures: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 2005;65(5):668–75.

    CAS  PubMed  Google Scholar 

  18. Matin N, Young SS, Williams B, LaFrance WC Jr, King JN, Caplan D, Chemali Z, Weilburg JB, Dickerson BC, Perez DL. Neuropsychiatric associations with gender, illness duration, work disability, and motor subtype in a U.S. functional neurological disorders clinic population. J Neuropsychiatry Clin Neurosci. 2017;29(4):375–82.

    PubMed  Google Scholar 

  19. Hopp JL, Anderson KE, Krumholz A, Gruber-Baldini AL, Shulman LM. Psychogenic seizures and psychogenic movement disorders: are they the same patients? Epilepsy Behav. 2012;25(4):666–9.

    CAS  PubMed  Google Scholar 

  20. Driver-Dunckley E, Stonnington CM, Locke DE, Noe K. Comparison of psychogenic movement disorders and psychogenic nonepileptic seizures: is phenotype clinically important? Psychosomatics. 2011;52(4):337–45.

    PubMed  Google Scholar 

  21. van Merode T, de Krom MC, Knottnerus JA. Gender-related differences in non-epileptic attacks: a study of patients’ cases in the literature. Seizure. 1997;6(4):311–6.

    PubMed  Google Scholar 

  22. Gale SD, Hill SW, Pearson C. Seizure semiology in males with psychogenic nonepileptic seizures is associated with somatic complaints. Epilepsy Res. 2015;115:153–7.

    PubMed  Google Scholar 

  23. Say GN, Tasdemir HA, Ince H. Semiological and psychiatric characteristics of children with psychogenic nonepileptic seizures: gender-related differences. Seizure. 2015;31:144–8.

    PubMed  Google Scholar 

  24. Asadi-Pooya AA, Emami M, Emami Y. Gender differences in manifestations of psychogenic non-epileptic seizures in Iran. J Neurol Sci. 2013;332(1–2):66–8.

    CAS  PubMed  Google Scholar 

  25. Roelofs K, Pasman J. Stress, childhood trauma, and cognitive functions in functional neurologic disorders. Hand Clin Neurol. 2016;139(Functional Neurological Disorders):139–55.

    CAS  Google Scholar 

  26. Oto M, Conway P, McGonigal A, Russell AJ, Duncan R. Gender differences in psychogenic non-epileptic seizures. Seizure. 2005;14(1):33–9.

    CAS  PubMed  Google Scholar 

  27. Thomas AA, Preston J, Scott RC, Bujarski KA. Diagnosis of probable psychogenic nonepileptic seizures in the outpatient clinic: does gender matter? Epilepsy Behav. 2013;29(2):295–7.

    PubMed  Google Scholar 

  28. Wang V, Salinsky M. Neurologic and medical factors. In: Dworetzky B, Baslet G, editors. Psychogenic nonepileptic seizures: towards the integration of care. New York: Oxford; 2017. p. 67–85.

    Google Scholar 

  29. Baslet G, Seshadri A, Bermeo-Ovalle A, Willment K, Myers L. Psychogenic non-epileptic seizures: an updated primer. Psychosomatics. 2016;57(1):1–17.

    PubMed  Google Scholar 

  30. Reuber M, Brown RJ. Understanding psychogenic nonepileptic seizures-phenomenology, semiology and the integrative cognitive model. Seizure. 2017;44:199–205.

    PubMed  Google Scholar 

  31. Edwards MJ. Neurobiologic theories of functional neurologic disorders. Hand Clin Neurol. 2016;139(Functional Neurological Disorders):131–7.

    Google Scholar 

  32. Liepert J, Hassa T, Tuscher O. Electrophysiological correlates of motor conversion disorder. Mov Disord. 2008;23(15):2172–6.

    Google Scholar 

  33. Bakvis P, Roelofs K, Kuyk J, Edelbroek PM, Swinkels WA, Spinhoven P. Trauma, stress, and preconscious threat processing in patients with psychogenic nonepileptic seizures. Epilepsia. 2009;50(5):1001–11.

    PubMed  Google Scholar 

  34. Reinsberger C, Sarkis R, Papadelis C, Doshi C, Perez DL, Baslet G, et al. Autonomic changes in psychogenic nonepileptic seizures: toward a potential diagnostic biomarker? Clin EEG Neurosci. 2015;46(1):16–25.

    PubMed  Google Scholar 

  35. Atmaca M, Aydin A, Tezcan E, Poyraz AK, Kara B. Volumetric investigation of brain regions in patients with conversion disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2006;30(4):708–13.

    Google Scholar 

  36. Nicholson TR, Aybek S, Kempton MJ, Daly EM, Murphy DG, David AS, et al. A structural MRI study of motor conversion disorder: evidence of reduction in thalamic volume. J Neurol Neurosurg Psychiatry. 2014;85(2):227–9.

    CAS  PubMed  Google Scholar 

  37. Aybek S, Nicholson TR, Draganski B, Daly E, Murphy DG, David AS, et al. Grey matter changes in motor conversion disorder. J Neurol Neurosurg Psychiatry. 2014;85(2):236–8.

    PubMed  Google Scholar 

  38. Labate A, Cerasa A, Mula M, Mumoli L, Gioia MC, Aguglia U, et al. Neuroanatomic correlates of psychogenic nonepileptic seizures: a cortical thickness and VBM study. Epilepsia. 2012;53(2):377–85.

    PubMed  Google Scholar 

  39. Aybek S, Vuilleumier P. Imaging studies of functional neurologic disorders. Hand Clin Neurol. 2016;139(Functional Neurological Disorders):73–84.

    CAS  Google Scholar 

  40. Voon V, Cavanna AE, Coburn K, Sampson S, Reeve A, LaFrance WC, et al. Functional neuroanatomy and neurophysiology of functional neurological disorders (conversion disorder). J Neuropsychiatry Clin Neurosci. 2016;28(3):168–90.

    PubMed  Google Scholar 

  41. Asadi-Pooya AA. Psychogenic nonepileptic seizures and sex differences in stress responses. Epilepsia. 2016;57(5):853.

    PubMed  Google Scholar 

  42. Hall-Patch L, Brown R, House A, Howlett S, Kemp S, Lawton G, et al. Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures. Epilepsia. 2010;51(1):70–8.

    PubMed  Google Scholar 

  43. Razvi S, Mulhern S, Duncan R. Newly diagnosed psychogenic nonepileptic seizures: health care demand prior to and following diagnosis at a first seizure clinic. Epilepsy Behav. 2012;23(1):7–9.

    PubMed  Google Scholar 

  44. Jirsch JD, Ahmed SN, Maximova K, Gross DW. Recognition of psychogenic nonepileptic seizures diminishes acute care utilization. Epilepsy Behav. 2011;22(2):304–7.

    CAS  PubMed  Google Scholar 

  45. Ness D. Physical therapy management for conversion disorder: case series. J Neurol Phys Ther. 2007;31(1):30–9.

    PubMed  Google Scholar 

  46. Nielsen G, Ricciardi L, Demartini B, Hunter R, Joyce E, Edwards MJ. Outcomes of a 5-day physiotherapy programme for functional (psychogenic) motor disorder. J Neurol. 2015;262(3):674–81.

    CAS  PubMed  Google Scholar 

  47. Jordbru AA, Smedstad LM, Klungsoyr O, Martinsen EW. Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. J Rehabil Med. 2014;46(2):181–7.

    PubMed  Google Scholar 

  48. Voon V, Lang AE. Antidepressant treatment outcomes of psychogenic movement disorder. J Clin Psychiatry. 2005;66(12):1529–34.

    CAS  PubMed  Google Scholar 

  49. Pintor L, Baillus E, Matrai S, Carreno M, Donaire A, Boget T, et al. Efficiency of venlafaxine in patients with psychogenic nonepileptic seizures and anxiety and/or depressive disorders. J Neuropsychiatry Clin Neurosci. 2010;22(4):401–8.

    CAS  PubMed  Google Scholar 

  50. Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ. Pharmacological interventions for somatoform disorders in adults. Cochrane Database Syst Rev. 2014;11:CD010628.

    Google Scholar 

  51. LaFrance WC Jr, Baird GL, Barry JJ, Blum AS, Frank Webb A, Keitner GI, Machan JT, Miller I, Szaflarski JP. NES treatment trial (NEST-T) consortium. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry. 2014;71(9):997–1005.

    PubMed  Google Scholar 

  52. Goldstein LH, Chalder T, Chigwedere C, Khondoker MR, Moriarty J, Toone BK, et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures A pilot RCT. Neurology. 2010;74(24):1986–94.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Sharpe M, Walker J, Williams C, Stone J, Cavanagh J, Murray G, et al. Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology. 2011;77(6):564–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Williams C, Kent C, Smith S, Carson A, Sharpe M, Cavanagh J. Overcoming functional neurological symptoms: a five areas approach. London: Hodder Arnold; 2011.

    Google Scholar 

  55. Reiter JM, Andrews D, Reiter C, LaFrance WC. Taking control of your seizures workbook. New York: Oxford University Press; 2015.

    Google Scholar 

  56. Moene FC, Spinhoven P, Hoogduin KA, van Dyck R. A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychother Psychosom. 2002;71(2):66–76.

    PubMed  Google Scholar 

  57. Kompoliti K, Wilson B, Stebbins G, Bernard B, Hinson V. Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: randomized clinical trial. Parkinsonism Relat Disord. 2014;20(1):60–3.

    PubMed  Google Scholar 

  58. Mayor R, Howlett S, Grünewald R, Reuber M. Long-term outcome of brief augmented psychodynamic interpersonal therapy for psycho- genic nonepileptic seizures: seizure control and health care utilization. Epilepsia. 2010;51(7):1169–76.

    PubMed  Google Scholar 

  59. Barry JJ, Wittenberg D, Bullock KD, Michaels JB, Classen CC, Fisher RS. Group therapy for patients with psychogenic nonepileptic seizures: a pilot study. Epilepsy Behav. 2008;13(4):624–9.

    CAS  PubMed  Google Scholar 

  60. Myers L, Vaidya-Mathur U, Lancman M. Prolonged exposure therapy for the treatment of patients diagnosed with psychogenic non-epileptic seizures (PNES) and post-traumatic stress disorder (PTSD). Epilepsy Behav. 2017;66:86–92.

    PubMed  Google Scholar 

  61. Baslet G, Dworetzky B, Perez DL, Oser M. Treatment of psychogenic nonepileptic seizures: updated review and findings from a mindfulness-based intervention case series. Clin EEG Neurosci. 2015;46(1):54–64.

    PubMed  Google Scholar 

  62. Kuyk J, Siffels MC, Bakvis P, Swinkels WA. Psychological treatment of patients with psychogenic non-epileptic seizures: an outcome study. Seizure. 2008;17(7):595–603.

    PubMed  Google Scholar 

  63. Zaroff CM, Myers L, Barr WB, Luciano D, Devinsky O. Group psycho-education as treatment for psychological nonepileptic seizures. Epilepsy Behav. 2004;5(4):587–92.

    PubMed  Google Scholar 

  64. Chastan N, Parain D. Psychogenic paralysis and recovery after motor cortex transcranial magnetic stimulation. Mov Disord. 2010;25(10):1501–4.

    PubMed  Google Scholar 

  65. Jaeger S, Steinert T, Uhlmann C, Flammer E, Bichescu-Burian D, Tschoke S. Dissociation in patients with borderline personality disorder in acute inpatient care – a latent profile analysis. Compr Psychiatry. 2017;78:67–75.

    PubMed  Google Scholar 

  66. Taylor MA, Viadya NA. Descriptive psychopathology; signs and symptoms of behavioral disorders. Cambridge, UK: Cambridge University Press; 2009.

    Google Scholar 

  67. Steinberg M. The spectrum of depersonalization: assessment and treatment. In: Tasman A, Goldfinger SM, editors. American psychiatric press review of psychiatry, vol. 10. Washington, DC: American Psychiatric Press; 1991. p. 223–47.

    Google Scholar 

  68. Brand BL, Lanius R, Vermetten E, et al. Where are we going? An update an assessment, treatment, and neurobiological research in dissociative disorders as we move toward the DSM-5. J Trauma Dissociation. 2012;13(1):9–31.

    PubMed  Google Scholar 

  69. Kluft RP, editor. Childhood antecedents of multiple personality. Washington, DC: American Psychiatric Press; 1985.

    Google Scholar 

  70. Foote B, Smolin Y, Kaplan M, Legatt ME, Lipschitz D. Prevalence of dissociative disorders in psychiatric outpatients. Am J Psychiatr. 2006;163(4):623–9.

    PubMed  Google Scholar 

  71. Johnson JG, Cohen P, Kasen S, Brook JS. Dissociative disorders among adults in the community, impaired functioning, and axis I and II comorbidity. J Psychiatr Res. 2006;40(2):131–40.

    PubMed  Google Scholar 

  72. Lee WE, Kwok CHT, Hunter ECM, Richards M, David AS. Prevalence and childhood antecedents of depersonalization syndrome in a UK birth cohort. Soc Psychiatry Psychiatr Epidemiol. 2012;47(2):253–61.

    PubMed  Google Scholar 

  73. Hunter EC, Sierra M, David AS. The epidemiology of depersonalisation and derealisation: a systematic review. Soc Psychiatry Psychiatr Epidemiol. 2004;39(1):9–18.

    CAS  PubMed  Google Scholar 

  74. Stein DJ, Koenen KC, Friedman MJ, Hill E, McLaughlin KA, Petukhova M, et al. Dissociation in posttraumatic stress disorder: evidence from the world mental health surveys. Biol Psychiatry. 2013;73(4):302–12.

    PubMed  Google Scholar 

  75. Rodewald F, Wilhelm-Goling C, Emrich HM, Reddemann L, Gast U. Axis-I comorbidity in female patients with dissociative identity disorder and dissociative identity disorder not otherwise specified. J Nerv Ment Dis. 2011;199(2):122–31.

    PubMed  Google Scholar 

  76. Van Der Kloat D, Giesbrecht T, Franck E, Van Gastel A, De Volder I, Van Den Eede F, et al. Dissociative symptoms and sleep parameters – an all-night polysomnography study in patients with insomnia. Compr Psychiatry. 2013;54(6):658–64.

    Google Scholar 

  77. Lyssenko L, Schmahl C, Bockhacker L, Vonderlin R, Bohus M, Kleindienst N. Dissociation in psychiatric sisorders: a meta-analysis of studies using the dissociative experiences scale. Am J Psychiatry. 2017;175:37–46.

    PubMed  Google Scholar 

  78. Lambert MV, Sierra M, Phillips ML, David AS. The organic spectrum of depersonalization. A review plus four new cases. J Neuropsychiat Clin Neurosci. 2002;14:141–54.

    Google Scholar 

  79. Allen JG, Smith WH. Diagnosing dissociative disorders. Bull Menn Clin. 1993;57(3):328–43.

    CAS  Google Scholar 

  80. Coons PM. The dissociative disorders: rarely considered and underdiagnosed. Psychiatr Clin N Am. 1998;21(3):637–64.

    CAS  Google Scholar 

  81. Putnam FW. Dissociation in children and adolescents: a developmental perspective. New York: The Guilford Press; 1997.

    Google Scholar 

  82. Dalenberg CJ, Brand BL, Gleaves DH, et al. Evaluation of the evidence for the trauma and fantasy models of dissociation. Psychol Bull. 2012;138(3):550–88.

    PubMed  Google Scholar 

  83. Silberg J. The dissociative child. Lutherville: Sidran Press; 1996.

    Google Scholar 

  84. Giesbrecht T, Lynn SJ, Lilienfeld SO, Merckelbach H. Cognitive processes in dissociation: an analysis of core theoretical assumptions. Psychol Bull. 2008;134(5):617–47.

    PubMed  Google Scholar 

  85. Krause-Utz A, Frost R, Winter D, Elzinga BM. Dissociation and alterations in brain function and structure: implications for borderline personality disorder. Curr Psychiatry Rep. 2017;19(1):6.

    PubMed  PubMed Central  Google Scholar 

  86. Perez DL, Matin N, Williams B, Tanev K, Makris N, LaFrance WC, et al. Cortical thickness alterations linked to somatoform and psychological dissociation in functional neurological disorders. Hum Brain Mapp. 2018;39(1):428–39.

    PubMed  Google Scholar 

  87. Van Huijsteen J, Vermetten E. The dissociative subtype of post-traumatic stress disorder: research update on clinical and neurobiological features. Curr Top Behav Neurosci. 2017;38:229–48.

    Google Scholar 

  88. Giesbrecht T, Jongen EM, Smulders FTY, Merckelbach H. Dissociation, resting EEG, and subjective sleep experiences in undergraduates. J Nerv Ment Dis. 2006;194(5):362–8.

    PubMed  Google Scholar 

  89. Okano K. Clinical handling of patients with dissociative disorders. Seishin Shinkeigaku Zasshi. 2015;117(6):399–412.

    PubMed  Google Scholar 

  90. Myrick AC, Chasson GS, Lanius RA, Leventhal B, Brand BL. Treatment of complex dissociative disorders: a comparison of interventions reported by community therapists versus those recommended by experts. J Trauma Dissociation. 2015;16(1):51–67.

    PubMed  Google Scholar 

  91. Weiner E, McKay D. A preliminary evaluation of repeated exposure for depersonalization and derealization. Behav Modif. 2012;37(2):226–42.

    PubMed  Google Scholar 

  92. Brand BL, McNary SW, Myrick AC, Classen CC, Lanius R, Lowenstein RJ, et al. A longitudinal naturalistic study of patients with dissociative disorders treated by community clinicians. Psychol Trauma: Theory Res Pract Policy. 2012;5:301–8.

    Google Scholar 

  93. Myrick AC, Webermann AR, Loewenstein RJ, Lanius R, Putnam FW, Brand BL. Six-year follow-up of the treatment of patients with dissociative disorders study. Eur J Psychotraumatol. 2017;8(1):1344080.

    PubMed  PubMed Central  Google Scholar 

  94. Lilienfeld SO. Psychological treatments that cause harm. Perspect Psychol Sci. 2007;2(1):53–70.

    PubMed  Google Scholar 

  95. Gentile JP, Dillon KS, Gillig PM. Psychotherapy and pharmacotherapy for patients with dissociative identity disorder. Innov Clin Neurosci. 2013;10(2):22–9.

    PubMed  PubMed Central  Google Scholar 

  96. Simeon D, Guralnik O, Schmeidler J, Knutelska M. Fluoxetine therapy in depersonalisation disorder: randomised controlled trial. Br J Psychiatry. 2004;185:31–6.

    PubMed  Google Scholar 

  97. Stern TA, Rosenbaum JF, Fava M, et al. Massachusetts general hospital comprehensive clinical psychiatry. Waltham: Elsevier Health Sciences; 2008.

    Google Scholar 

  98. Sierra M, Phillips ML, Ivin G, Krystal J, David AS. A placebo-controlled, cross-over trial of lamotrigine in depersonlization disorder. J Psychopharmacol. 2003;17(1):103–5.

    CAS  PubMed  Google Scholar 

  99. Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, Limberger MF, Böhme R, Schmahl CG. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial. J Clin Psychiatry. 1999;60:598–60.

    CAS  PubMed  Google Scholar 

  100. Schmahl C, Kleindienst N, Limberger M, Ludascher P, Mauchnik J, Deibler P, et al. Evaluation of naltrexone for dissociative symptoms in borderline personality disorder. Int Clin Psychopharmacol. 2012;27(1):61–8.

    PubMed  Google Scholar 

  101. Jay EL, Nestler S, Sierra M, McLelland J, Kekic M, David AS. Ventrolateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of depersonalization disorder: a consecutive case series. Psychiatry Res. 2016;240:118–22.

    PubMed  PubMed Central  Google Scholar 

  102. Brown RJ, Cardena E, Nijenhuis E, Sar V, van der Hart O. Should conversion disorder be reclassified as a dissociative disorder in DSM V? Psychosomatics. 2007;48(5):369–78.

    PubMed  Google Scholar 

  103. Nijenhuis ER. Somatoform dissociation and somatoform dissociative disorders. In: Dell P, O’Neil J, editors. Dissociation and the dissociative disorders: DSM-V and beyond. New York: Routledge; 2009. p. 259–76.

    Google Scholar 

  104. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.

    Google Scholar 

  105. Nijenhuis ER, Van Dyck R, Spinhoven P, van der Hart O, Chatrou M, Vanderlinden J, et al. Somatoform dissociation discriminates among diagnostic categories over and above general psychopathology. Aust N Z J Psychiatry. 1999;33(4):512–20.

    Google Scholar 

  106. Nijenhuis ER, Van Dyck R, Ter Kuile MM, Moutitis MJE, Soinhoven P, van der Hart O. Evidence for associations among somatoform dissociation, psychological dissociation and reported trauma in patients with chronic pelvic pain. J Psychosom Obstet Gynecol. 2003;24(2):87–98.

    CAS  Google Scholar 

  107. Sar V, Kundakci T, Kiziltan E, Bakim B, Bozkurt O. Differentiating dissociative disorders from other diagnostic groups through somatoform dissociation in Turkey. J Trauma Dissociation. 2000;1(4):67–80.

    Google Scholar 

  108. Sar V, Akyüz G, Kundakçi T, Kiziltan E, Dogan O. Childhood trauma, dissociation, and psychiatric comorbidity in patients with conversion disorder. Am J Psychiatry. 2004;161(12):2271–6.

    PubMed  Google Scholar 

  109. Tezcan E, Atmaca M, Kuloglu M, Gecici O, Buyukbayram A, Tutkun H. Dissociative disorders in Turkish inpatients with conversion disorder. Compr Psychiatry. 2003;44(4):324–30.

    PubMed  Google Scholar 

  110. Spitzer C, Spelsberg B, Grabe HJ, Mundt B, Freyberger HJ. Dissociative experiences and psychopathology in conversion disorders. J Psychosom Res. 1999;46(3):291–4.

    CAS  PubMed  Google Scholar 

  111. Espirito-Santo H, Pio-Abreu JL. Psychiatric symptoms and dissociation in conversion, somatization and dissociative disorders. Aust N Z J Psychiatry. 2009;43(3):270–6.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Geoffrey Raynor .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Raynor, G., Baslet, G. (2019). Functional Neurological Disorder and Dissociative Disorders in Women. In: O’Neal, M. (eds) Neurology and Psychiatry of Women. Springer, Cham. https://doi.org/10.1007/978-3-030-04245-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-04245-5_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-04244-8

  • Online ISBN: 978-3-030-04245-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics